3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
3
Gynecologic
2
Sarcoma
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Cervical Neoplasms
2
Endometrial Neoplasms
1
Interventions
Paclitaxel
35
Bevacizumab
31
Carboplatin
29
pembrolizumab
25
Specimen Handling
20
Magnetic Resonance Spectroscopy
18
olaparib
16
Cisplatin
15
liposomal doxorubicin
13
Taxes
12
Immunoglobulin G
11
Gemcitabine
11
Disulfides
11
Topotecan
9
Nivolumab
9
Cyclophosphamide
9
Biopsy
8
fludarabine
7
Doxorubicin
7
mirvetuximab soravtansine
6
niraparib
5
Radiation
5
Oxaliplatin
5
Fulvestrant
5
Fluorouracil
5
trastuzumab deruxtecan
4
durvalumab
4
cediranib
4
Platinum
4
Megestrol Acetate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Radiation Dose Hypofractionation
×
Gynecologic
×
30 days
×
Clear all
NCT07605507
2026-05-26
HYPOCx-iRex
Siriraj Hospital
Phase NA
Active not recruiting
40 enrolled
NCT07595224
2026-05-19
PostOP HYPOCxE
Siriraj Hospital
Phase NA
Recruiting
120 enrolled